Common recognition principles of B-cell receptor immunoglobulins in CLL and autoimmune disorders

被引：0
|
作者：
Binder, M. [1 ]
Seismann, H. [1 ]
Wehr, C. [2 ]
Ummanni, R. [3 ]
Balabanov, S. [1 ]
Trepel, M. [1 ]
机构：
[1] Uniklin Hamburg Eppendorf, Hamburg, Germany
[2] Uniklin Freiburg, Freiburg, Germany
[3] DKFZ, Heidelbert, Germany
来源：
ONKOLOGIE | 2011年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：195 / 195
页数：1
相关论文
共 50 条
  • [41] B-cell tolerance to the B-cell receptor variable regions
    Jacobsen, Johanne T.
    Sundvold-Gjerstad, Vibeke
    Skjeldal, Frode M.
    Andersen, Jan-Terje
    Abrahamsen, Greger
    Bakke, Oddmund
    Spurkland, Anne
    Bogen, Bjarne
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2013, 43 (10) : 2577 - 2587
  • [42] Targeting of B-cell receptor signalling in B-cell malignancies
    Jerkeman, M.
    Hallek, M.
    Dreyling, M.
    Thieblemont, C.
    Kimby, E.
    Staudt, L.
    JOURNAL OF INTERNAL MEDICINE, 2017, 282 (05) : 415 - 428
  • [43] Ectopic Lck expression in CLL demarcates intratumoral subpopulations with aberrant B-cell receptor signaling
    Theofani, Efthymia
    Alexis, Spyridon
    Costeas, Paul
    Andriopoulos, Christos
    Feleskoura, Georgia
    Zikos, Panagiotis
    Aktypi, Anthi
    Spyridonidis, Alexandros
    Nika, Konstantina
    BLOOD ADVANCES, 2018, 2 (08) : 877 - 882
  • [44] Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL
    Shukla, Ashima
    Rai, Karan
    Shukla, Vipul
    Chaturvedi, Nagendra K.
    Bociek, R. Gregory
    Pirruccello, Samuel J.
    Band, Hamid
    Lu, Runqing
    Joshi, Shantaram S.
    BLOOD, 2016, 127 (19) : 2310 - 2321
  • [45] RUXOLITINIB INDUCES APOPTOSIS OF B-CELL RECEPTOR STIMULATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) CELLS
    Rozovski, U.
    Wu, J. Yuan
    Harris, D.
    Liu, Z.
    Li, P.
    Hazan-Halevi, I.
    Ferrajoli, A.
    Burger, J.
    O'brien, S.
    Wierda, W.
    Keating, M.
    Estrov, Z.
    HAEMATOLOGICA, 2014, 99 : 38 - 38
  • [46] B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramides
    Schwamb, Janine
    Feldhaus, Valeska
    Baumann, Michael
    Patz, Michaela
    Brodesser, Susanne
    Brinker, Reinhild
    Claasen, Julia
    Pallasch, Christian P.
    Hallek, Michael
    Wendtner, Clemens-Martin
    Frenzel, Lukas P.
    BLOOD, 2012, 120 (19) : 3978 - 3985
  • [47] Tyrosine kinase inhibitors as potential drugs for B-cell lymphoid malignancies and autoimmune disorders
    Robak, Tadeusz
    Robak, Ewa
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (07) : 921 - 947
  • [48] Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families
    Goldin, Lynn R.
    Lanasa, Mark C.
    Slager, Susan L.
    Cerhan, James R.
    Vachon, Celine M.
    Strom, Sara S.
    Camp, Nicola J.
    Spector, Logan G.
    Leis, Jose F.
    Morrison, Vicki A.
    Glenn, Martha
    Rabe, Kari G.
    Achenbach, Sara J.
    Algood, Sallie D.
    Abbasi, Fatima
    Fontaine, Laura
    Yau, Michelle
    Rassenti, Laura Z.
    Kay, Neil E.
    Call, Timothy G.
    Hanson, Curtis A.
    Weinberg, J. Brice
    Marti, Gerald E.
    Caporaso, Neil E.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 151 (02) : 152 - 158
  • [49] B cell abnormality and autoimmune disorders
    Tsubata, T
    AUTOIMMUNITY, 2005, 38 (05) : 331 - 337
  • [50] Characterization of microvesicles in B-Cell chronic lymphocytic leukemia (CLL): A potential mediator in CLL B cell disease progression?
    Ghosh, Asish K.
    Kay, Neil E.
    BLOOD, 2007, 110 (11) : 230A - 230A
12345